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Abstract Syntaxin and SNAP-25 (synaptosome-associated 
protein of 25 kDa), associated with the neuronal plasmalemma, 
and synaptobrevin, a membrane protein of synaptic vesicles, are 
essential components of the exocytotic apparatus of synaptic 
vesicles. All three can be proteolytically cleaved by tetanus and/ 
or botulinum neurotoxins. As a consequence of their cleavage, 
exocytosis of neurotransmitters is blocked. In adrenal chromaffin 
cells botulinum neurotoxin A only incompletely inhibits exocy- 
tosis. This incomplete inhibition of exocytosis is associated with 
only partial cleavage of SNAP-25 by the toxin, indicating that 
distinct pools of SNAP-25 nlay exist in chromaffin cells which 
differ in their sensitivities to botulinum neurotoxin A. In line with 
this result we localized SNAP-25 by immunogold electron 
microscopy not only to the plasmalemma but also to the 
chromaffin vesicle membrane. Moreover, in addition to SNAP- 
25 monomers, stable SNAP-25/syntaxin heterodimers were 
found in chromaffin cells. Subfractionation studies revealed the 
presence of SNAP-25/syntaxin heterodimers in an enriched 
fraction of chromaffin vesicles. This complex proved to be stable 
in SDS, and SNAP-25 within heterodimers was resistant to 
proteolytic attack by botulinum neurotoxin A. We suggest hat 
these preexisting heterodimers may serve as receptors of soluble 
NSF attachment proteins (SNAP receptors) during chromaffin 
vesicle exocytosis. 
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1. Introduction 
Tetanus and botulinum neurotoxins inhibit neurotransmit- 
ter release by cleaving essential components of the exocytosis 
apparatus in synapses. Tetanus toxin and botulinum neuro- 
toxins B, D, F and G attack synaptobrevin (also referred to as 
VAMP, vesicle-associated membrane protein), botulinum neu- 
rotoxins A and E proteolyse synaptosome-associated protein 
of 25 kDa (SNAP-25), and botulinum neurotoxin C cleaves 
syntaxin (also referred to as HPC-1) (reviewed in [1]). Synap- 
tobrevin, an integral membrane protein of synaptic vesicles, 
and the plasma membrane proteins SNAP-25 and syntaxin 
have also been identified as major components of a complex 
formed in detergent extracts of brain together with N-ethyl- 
maleimide-sensitive fusion protein (NSF) and soluble NSF 
attachment proteins (SNAPs) [2]. Because NSF/SNAP couple 
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vesicular synaptobrevin with SNAP-25 and syntaxin localized 
at the plasmalemmal target membrane, these proteins have 
been termed vesicular and target SNAP receptors (v-SNAREs 
and t-SNAREs), respectively. In detergents ynaptobrevin, 
SNAP-25 and syntaxin first assemble as a 7S complex which, 
after binding of SNAPs and NSF, forms a 20S complex, 
which dissociates in the presence of ATP as a result of the 
ATPase activity of NSF [3 5]. Studies of recombinant pro- 
teins or solubilized brain in detergents revealed that mono- 
mers of SNAP-25 and syntaxin, heterodimers (between syn- 
taxin and SNAP-25, synaptobrevin and syntaxin or 
synaptobrevin a d SNAP-25) and heterotrimers between the 
three membrane proteins bind SNAPs [5 l l]. From these 
studies carried out in the presence of detergents it is unknown 
whether such heterodimers or heterotrimers exist in intact 
membranes of secretory cells. 
Tetanus and botulinum neurotoxins inhibit exocytosis not 
only of synaptic vesicles but also of secretory granules. Cleav- 
age of the v-SNARE synaptobrevin results in the inhibition of 
exocytosis by adrenal chromaffin and pheochromocytoma 
cells [12,13]. Catecholamine r lease from adrenal chromaffin 
cells, vasopressin release from neurohypophysial terminals 
and insulin release from pancreatic 13 cells is inhibited by 
botulinum neurotoxin A [14-18]. However, the variable cleav- 
age of SNAP-25 in pancreatic [3cells, the incomplete inhib- 
ition of vasopressin and catecholamine r lease and the prefer- 
ential attack of ATP-dependent priming by botulinum 
neurotoxin A suggested that this toxin may have molecular 
targets of different sensitivities [14-21]. 
Here, we report for the first time that besides SNAP-25 
monomers adrenal chromaffin cells also contain SNAP-25/ 
syntaxin heterodimers. The latter are stable in SDS and resist- 
ant to botulinum neurotoxin A. Interestingly, we also found 
SNAP-25/syntaxin heterodimers, but virtually no SNAP-25 
monomers in the membrane of chromaffin secretory granules. 
However, the original SNARE hypothesis predicts that 
SNAP-25 and syntaxin play their roles at the plasmalemma 
as t-SNAREs [2,3,22]. Our finding that complexes between 
SNAP-25 and syntaxin exist at the membrane of the vesicular 
membrane and the observation that such complexes avidly 
bind SNAPs [4,7] suggest hat SNAP-25/syntaxin heterodi- 
mers may serve as v-SNAREs during exocytosis of chromaffin 
granules. 
2. Materials and methods 
2.1. Cell culture, permeabilization and incubation of ehromaffin cells 
with BoNT/A 
Bovine adrenal chromaffin cells were isolated and grown as de- 
scribed [23]. The cells were plated at 3.5 7× l0 s cells/well. After 2-5 
days in culture Ca 2+ was removed from the cultures by three washes 
with a medium containing (in mM) 140 NaCI, 4.7 KC1, 1.2 KH2PO4, 
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1.2 MgSO4, 0.5 ascorbic acid, l l  glucose and 15 PIPES (pH 7.2) 
followed by washes with potassium glutamate medium (in mM: 150 
potassium glutamate, 0.5 EGTA, 5 EDTA, 10 PIPES, pH 7.2). The 
osmolarity of the media was maintained at 300 310 mosmol/kg. The 
cells were permeabilized (at 30°C for 2 min) with streptolysin O (63 
hemolytic units/well) in potassium glutamate medium containing 
2 mM Mg2+-ATP, 7.67 mM magnesium acetate, 0.1% bovine serum 
albumin (BSA) and 1 mM dithiothreitol [24]. The efficiency of per- 
meabilization (more than 95% of cells permeabilized) was checked 
with 0.04%, trypan blue in the above medium. The medium was 
then replaced by the same medium containing BoNT/A, followed by 
incubation for 25 min at 30°C. Finally, the cells were used in release 
experiments ( ee below) or the cells were lysed with 100 lal SDS-sam- 
ple buffer per well. Proteins (determined with the BCA method, 
Pierce, Oud-Beijerland, Netherlands) were subjected to SDS-PAGE 
followed by immunoblotting. 
2.2. Release of noradrenaline from permeabilized chromaffin cells 
Prior to the release experiments adrenal chromaffin cells were in- 
cubated for 1 h with [3H]noradrenaline (1.3 laCi/ml) in serum-free 
culture medium (DMEM) supplemented with 1 mM ascorbic acid. 
The cells were washed and permeabilized with SLO and incubated 
with BoNT/A as described above. Then the cells were stimulated for 
15 min at 30°C with potassium glutamate medium containing 30 p_M 
free Ca 2+. Basal release was determined in the same medium with no 
Ca 2+ added. Free Ca 2+ concentrations were calculated and checked 
with a Ca2+-specific electrode as described [25]. 
[3H]Noradrenaline r leased into the supernatant and remaining in 
the cells (after lysis with 0.2% SDS) was determined. Percentage of 
[3H]noradrenaline released was calculated using catecholamine con- 
tent of the lysate plus released catecholamines a 100%,. The values 
given are means_+ S.D. of three wells. 
2.3. Purification of chromaffin vesicle membranes and incubation with 
BoNTIA 
Chromaffin vesicles were isolated as described [26]. Briefly, bovine 
adrenal glands were perfused with 5 mM HEPES (pH 7.0), 150 mM 
NaC1, 5 mM EDTA. The medullae were homogenized in (20% w/v) 20 
mM MOPS (pH 7.0), 5 mM EDTA, 340 mM sucrose in a Teflon-to- 
glass homogenizer. From the postnuclear supernatant chromaffin ves- 
icles were harvested by centrifugation for 20 min at 12000Xg. They 
were placed on a discontinuous sucrose gradient consisting of 4 ml of 
2.4 M and 2 ml of each 2.2, 2.0, 1.8 and 1.6 M sucrose in 20 mM 
MOPS (pH 7.0), 5 mM EDTA. Centrifugation was done for 1 h at 
40000 rpm in a 50.2 Ti rotor (Beckman). Absorbance at 280 nm after 
precipitation of the protein with 10% (w/v) TCA was measured to 
conveniently locate chromaffin vesicles in the gradient while arylsul- 
fatase served to identify fractions containing lysosomes and other 
subcellular membranes [26]. The fractions enriched in chromaffin ves- 
icles (fractions 11-14) were recovered from the gradient, diluted 1:4 
with 20 mM MOPS (pH 7.0), 5 mM EDTA and centrifuged for 1 h at 
100 000 x g. The purified chromaffin vesicles were osmotically lysed by 
addition of a 10-fold excess of 20 mM MOPS (pH 7.0) with 5 mM 
EDTA. Chromaffin vesicle membranes were recovered by centrifuga- 
tion for 1 b at 100000xg and washed twice in potassium glutamate 
medium (see above) containing 6 mM magnesium acetate. The final 
pellet was suspended in the same medium and stored at 20°C until 
use. Chromaffin vesicle membranes (100 lag) were incubated in a vol- 
ume of 50 lal for 30 min at 30°C in potassium glutamate medium (see 
above) containing 100 nM BoNT/A and the different chemicals to be 
tested. For solubilization we used 1% (w/v) [3-D-octylglucopyranoside 
(OG). Lipids were extracted by chloroform/methanol [27] and the 
samples were boiled in SDS-sample buffer for 5 min or processed 
for without boiling. 
2.4. SDS-PAGE and immunoblotting 
The samples (15 lag/lane) of chromaffin vesicle membranes, chro- 
maffin cells in culture or homogenates of adrenal medullary tissue 
were separated on 12.5% or 5-15% gradient gels by SDS-PAGE [28] 
and blotted onto nitrocellulose [29]. Binding of the monoclonal anti- 
synaptobrevin antibody (CI. 10.1; diluted 1:2000) [30], of the mono- 
clonal anti-synaptotagmin I antibody (C1. 41.1; diluted 1:2000) [31], 
of monoclonal anti-SNAP-25 antibody (1:2000, SMI81, Sternberger 
Monoclonals Inc., Baltimore, MD, USA) and monoclonal anti-syn- 
taxin antibody (1:2000, CI. HPC-1, Sigma Immuno Chemicals, Dei- 
senhofen, Germany) was detected by peroxidase-labelled anti-mouse 
IgG antibodies (1:3000, Dianova, Hamburg, Germany) and the en- 
hanced chemiluminescence method (Amersham Buchler, Braun- 
schweig, Germany). In some experiments after electrophoresis the 
bands of interest were cut out from the unstained acrylamide gels, 
left at room temperature or boiled for 5 min, placed on top of the 
stacking el and subjected again to electrophoresis. 
2.5. Immunolocalization f SNAP-25 at the ultrastructural level 
Adrenal medullary tissue was fixed for 24 h at room temperature 
with 2.5%, paraformaldehyde and 0.25'%, glutaraldehyde in 100 rnM 
sodium cacodylate (pH 7.0). Then the tissue was dehydrated with 
ethanol (30% at 0°C, 50%, at -20°C, 80% and 100%, at -35°C) in- 
fltrated at -35°C with the hydrophilic resin Lowicryl K4M, which 
was polymerized with ultraviolet light for 2 days at -35°C and 3 days 
at room temperature [32]. Ultrathin sections on 75 mesh nickel grids 
were rinsed with PBS, 50 mM glycine in PBS, 0.5%, BSA in PBS, 5% 
normal goat serum followed by incubation (overnight at 4°C) with 
monoclonal anti-SNAP-25 antibody (SMI81, Sternberger Monoclo- 
nals Inc.) diluted 1:100 in PBS containing 1% BSA, monoclonal 
anti-synaptobrevin antibody (C1. 10.1; diluted 1:50) [30], or monoclo- 
nal anti-syntaxin antibody (1:50, C1. HPC-1, Sigma Immuno Chemi- 
cals). The sections were rinsed in PBS followed by incubation for 1 h 
at room temperature with Auro-Probe goat anti-mouse IgG-Au (5 
nm) (Amersham Buchler) diluted 1:100 in PBS containing 1% BSA. 
Silver enhancement was done with Aurion R-gent (Biotrend, Cologne, 
Germany) according to the recommendation f the manufacturer con- 
taining in addition 30% gum arabic. Finally sections were contrasted 
with 2%, uranylacetate (5 rain) and lead citrate (3 min). 
3. Results 
In agreement with previous reports [14-16] we found that 
exocytosis of secretory granules by adrenal chromaffin cells is 
only incompletely inhibited by BoNT/A. Ca2+-induced cate- 
cholamine release from bovine adrenal chromaffin cells per- 
meabil ized by SLO was significantly blocked by BoNT/A in 
concentrations a  low as 1 nM. Increasing the amounts of the 
neurotoxin 10- or 100-fold did not proport ionately affect the 
release (Fig. 1). In neurons blockade of transmitter release by 
BoNT/A is associated with cleavage of SNAP-25 [33,34]. In 
order to examine whether SNAP-25 is also cleaved by BoNT/ 
A in adrenal chromaffin cells we analyzed SNAP-25 in per- 
meabilized cells by immunoblott ing.  As shown at the bottom 
of Fig. 1 we found a conversion of the SNAP-25 immuno- 
reactive band of 25 kDa to a slightly smaller fragment at all 
BoNT/A concentrations tested. The extent of cleavage paral- 
leled the inhibit ion of exocytosis by the toxin and, even more 
important,  was as incomplete as the blockade of catechol- 
amine release. Higher concentrat ions of the toxin or longer 
periods of incubation did not result in further cleavage of 
SNAP-25. We interpreted these findings as evidence for the 
occurrence of SNAP-25 resistant to BoNT/A as well as 
SNAP-25 non-resistant to the toxin. If so, the non-resistant 
form should be rapidly cleaved within the chromaffin cells 
while the resistant form remains intact. Indeed we observed 
cleavage by 100 nM BoNT/A of 40% cellular SNAP-25 al- 
ready after 5 min and of 72% after 15 min, that is roughly the 
same extent of cleavage seen after 25 min (see Fig. 1). To- 
gether our data suggest hat the incomplete inhibit ion of exo- 
cytosis by BoNT/A is due to the occurrence of resistant or 
masked forms of SNAP-25 in adrenal chromaffin cells. 
We detected two forms of SNAP-25 with different electro- 
phoretic mobilities in adrenal medullary chromaffin cells by 
immunoblott ing.  In unboiled samples we observed immuno- 
reactive bands of 25 and 60 kDa. By contrast, when the same 
fractions were boiled prior to SDS-PAGE,  a single band of 25 
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Fig. I. Inhibition of exocytosis by botulinum neurotoxin A is paral- 
leled by cleavage of SNAP-25 in permeabilized adrenal chromalfin 
cells. After permeabilization the cells were incubated for 25 min at 
30°C with potassium glutamate medium (control), 1, 10, or 100 nM 
BoNT/A in potassium glutamate medium (see Section 2). Then the 
cells were stimulated for 15 min at 30°C with potassium glutamate 
medium containing 30 ~tM free Ca 2+ (filled bars) or no Ca 2+ (open 
bars) and the percentage of [3H]noradrenaline released into the 
supernatant was determined. Note that the inhibition of Ca2~--in - 
duced catecholamine r lease was incomplete, even at the highest 
BoNT/A concentration used. Data are means+ S.D. of three wells. 
After permeabilization with SLO and incubation of the cells with 
different concentration of BoNT/A for 25 min at 30°C, SDS-sample 
buffer was added followed by boiling, SDS-PAGE and immunoblot- 
ting. SNAP-25 (S-25) was visualized using the enhanced chemilumi- 
nescence method. SNAP-25 is incompletely cleaved in a dose-de- 
pendent manner by BoNT/A yielding in a slightly smaller product. 
The relative amounts of SNAP-25 and the cleavage as determined 
by densitometry are given at the bottom. 
kDa was found (Fig. 2). The nature of the two forms of 
SNAP-25 became apparent by probing blots of chromaffin 
cells with an antibody directed against syntaxin. We found 
an imuaunoreactive band of 60 kDa if unboiled samples 
were analyzed but an immunoreactive band of 35 kDa if the 
samples were heated prior to PAGE (Fig. 2). These observa- 
tions are compatible with the idea that SNAP-25/syntaxin 
heterodimers of 60 kDa are present in adrenal chromaffin cells 
which are stable in SDS at room temperature but are broken 
down upon heating. A band indicating syntaxin monomers is 
barely detectable in blots of unboiled samples. In contrast 
SNAP-25 monomers are present indicating the existence of 
a pool of SNAP-25 monomers in addition to SNAP-25/syn- 
taxin heterodimers in adrenal chromatfin cells. 
Observations at the light microscopic level have suggested 
that in chromaffin cells SNAP-25 is primarily found on the 
plasmalemma [35,36]. At the ultrastructural level we con- 
firmed this localization (Fig. 3a). However, in addition we 
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found SNAP-25 associated with chromaffin vesicle mem- 
branes (Fig. 3b,c). As positive controls we used antibodies 
directed against synaptobrevin, an established protein of the 
chromaffin vesicle membrane [12,37] as well as syntaxin [38]. 
Both antibodies decorated chromaffin vesicle membranes (Fig. 
3d,e). In controls, in which the first antibodies were omitted, 
none of these specific labeling features were observed. Thus 
our ultrastructural data show that SNAP-25 and syntaxin are 
associated with chromaffin vesicle membranes. 
We have subsequently purified chromaffin vesicles by differ- 
ential and density gradient centrifugation and analyzed frac- 
tions recovered from sucrose gradients for the presence of the 
putative members of the core of the exocytosis apparatus, 
synaptobrevin, syntaxin and SNAP-25. We were interested 
to know whether SNAP-25 monomers and the stable 
SNAP-25/syntaxin heterodimers detected in adrenal chromaf- 
fin cells (see above) are present in chromaffin vesicles and 
whether SNAP-25 present in this subcellular location can be 
cleaved by BoNT/A. We found (see Fig. 4) that in addition to 
synaptobrevin chromaffin vesicles (fractions 11 14) possess 
SNAP-25 and syntaxin, confirming our ultrastructural data 
(see above) and earlier observations [12,38]. Chromaffin gran- 
ules purified after differential centrifugation, first on a Percoll 
gradient and subsequently on a sucrose gradient [26], also 
contained synaptobrevin, syntaxin and SNAP-25 (not shown). 
The distribution of SNAP-25 in the gradient (see Fig. 4, lower 
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Fig. 2. Heterodimers of SNAP-25 and syntaxin are present in adre- 
nal chromaffin cells. In unboiled samples of chromaffin cells SNAP- 
25 (S-25) predominates. However, an additional immunoreactive 
band of 60 kDa is detectible. By contrast in boiled samples only 
SNAP-25 is observed. In unboiled samples the major syntaxin (Sx)- 
immunoreactive band exhibits a molecular weight of 60 kDa and a 
faint band of 35 kDa. A major band of authentic syntaxin is only 
found in boiled samples. 
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Fig. 3. Immunolocalization f SNAP-25, synaptobrevin and syntaxin in chromaffin cells. During immunogold localization of SNAP-25 in ultra- 
thin sections of adrenal medulla silver-enhanced gold particles were found to be associated with the plasmalemma ( ) and with chromaffin vesi- 
cle membranes (b,c). Chromaffin vesicle membranes were also decorated if antibodies directed against synaptobrevin (d) or syntaxin (e) were 
used. Bars, 0.1 lain. 
panel) was bimodal:  it was found in the chromaffin vesicle 
fractions (which contain synaptobrevin as a marker) and, in 
larger amounts,  in fractions 15 20 equil ibrating at lower su- 
crose densities which contain lysosomes (Fig. 4). The low 
amounts of synaptobrevin and the hump in the absorbance 
at 280 nm (fraction 17) may indicate that also a few immature 
and lighter chromaffin vesicles exist in these fractions. Since 
these fractions contain several SNAP-25 immunoreactive 
bands it is likely that SNAP-25/syntaxin complexes with other 
proteins. The precise nature of these complexes was not 
further analyzed in this study. We focused on fractions 11- 
14 which represent a homogeneous populat ion of chromaffin 
equil ibrating at 1 .62.0  M sucrose (see Section 2 and [12,26]), 
which, besides synaptobrevin and syntaxin, contain part of 
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Fig. 4. Sucrose density gradient fractionation of adrenal chromaffin vesicles. Chromaffin vesicles, obtained by differential centrifugation, were 
further purified on a discontinuous sucrose gradient (see Section 2). In agreement with previous reports [12,38], synaptobrevin (Sb) and syntaxin 
(Sx) are present in fractions 11-14 containing chromaffin vesicles characterized also by the highest peak of absorbance at 280 nm determined in
the TCA supernatant of the fractions (top). SNAP-25 exhibits a bimodal distribution. It is present in the chromaffin vesicle fractions and in 
lighter fractions containing lysosomes (see arylsulfatase activities hown at the top). The apparent molecular weight of the immunoreactive 
band was 60 kDa (arrow). Note that the samples used for the SNAP-25 immunoblot were not boiled but kept at room temperature (RT). 
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Fig. 5. Heterodimers of SNAP-25 and syntaxin in chromaffin vesicle membranes. In unboiled samples of chromaffin vesicle membranes a 
SNAP-25 (S-25) form of 60 kDa predominates. In contrast in boiled samples SNAP-25 exhibited a molecular weight of 25 kDa (A). The inten- 
sity of the syntaxin (Sx) band of 35 kDa increases upon boiling of the samples. The immunoreactive band of 60 kDa observed in unboiled 
samples was identified by reelectrophoresis of the material as a complex of SNAP-25 and syntaxin (B). 
the cellular SNAP-25 (Fig. 4). It should be noted that the 
samples analyzed for SNAP-25 were not boiled prior to 
SDS-PAGE. Interestingly the molecular weight of the 
SNAP-25 immunoreactive band in the blots was about 60 
kDa, that is about 35 kDa larger than that of authentic 
SNAP-25. 
We harvested the chromaffin vesicle fractions (11-14) from 
the sucrose gradients, isolated their membranes ( ee Section 
2), and analyzed them further. Again, in unboiled samples the 
anti-SNAP-25 antibody labelled a band of 60 kDa (Fig. 5A). 
Boiling of the samples caused a shift of the immunoreactive 
band to 25 kDa (Fig. 5A). The difference in electrophoretic 
mobility during SDS-PAGE of boiled and unboiled samples 
suggested the presence of a complex of SNAP-25 and syntaxin 
in chromaffin vesicle membranes. Moreover an antibody di- 
rected against syntaxin revealed an immunoreactive band of 
60 kDa in addition to syntaxin of 35 kDa in blots of unboiled 
samples (Fig. 5A) and only a syntaxin immunoreactive band 
of 35 kDa after boiling. Additional experiments provided evi- 
dence that the immunoreactive band of 60 kDa represents a 
heterodimer of syntaxin and SNAP-25. Cutting out the 60 
kDa band from the acrylamide gels followed by boiling and 
reelectrophoresis resulted in a band of 35 kDa immunoreac- 
tive with the antibody directed against syntaxin and a band of 
25 kDa immunoreactive with the antibody directed against 
SNAP-25 (Fig. 5B). Thus it is evident that SNAP-25 localized 
ultrastructurally to chromaffin vesicles forms a complex with 
syntaxin that is stable in SDS at room temperature but dis- 
assembles upon boiling. Synaptobrevin was not found in a 
complex stable in SDS which is consistent with the observa- 
tion that synaptobrevin of chromaffin vesicle membranes i  
readily cleaved by tetanus toxin [12], while complexes of syn- 
aptobrevin with syntaxin and SNAP-25 formed in solubilized 
brain are resistant to tetanus toxin [39]. SNAP-25 monomers, 
detected uring the analysis of whole chromaffin cells (see Fig. 
2), were absent from chromaffin vesicle membranes but syn- 
taxin exists also as a monomer within the membranes (Fig. 
5A). Thus chromaffin vesicle membranes differ in the types of 
monomers present in addition to the SNAP-25/syntaxin het- 
erodimers when compared to total cellular membranes. 
We also investigated the sensitivity to BoNT/A of SNAP-25 
in chromaffin vesicle membranes. We found that SNAP-25 
was resistant to BoNT/A under all circumstances tested with 
the exception of the addition of OG where a small fraction of 
SNAP-25 was cleaved (Fig. 6). This detergent caused the sol- 
ubilization of SNAP-25 from the membranes (not shown). 
Preincubation at room temperature or boiling in 1% OG 
(see Section 2) did not change the electrophoretic mobility 
of SNAP-25 suggesting that OG, unlike SDS, does not cause 
the dissociation of the heterodimers but alters the conforma- 
tion of SNAP-25, which apparently results in a slow attack of 
BoNT/A. In summary it can be concluded that vesicular 
SNAP-25 bound to syntaxin is resistant to BoNT/A. More- 
over immunocytochemistry of SNAP-25 at the ultrastructural 
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Fig. 6. SNAP-25 of chromaffin vesicles is resistant o botulinum 
neurotoxin A. Chromaffin vesicle membranes prepared from chro- 
maffin granules recovered from the sucrose density gradients (see 
Section 2) were incubated for 30 rain with 100 nM BoNT/A. The 
different additions (20 mM DTT, 1% OG, BoNT/A) indicated at 
the top did not change syntaxin (Sx)- or synaptotagmin (St)-immu- 
noreactive bands in the boiled samples. Only SNAP-25 (S-25) was 
partly attacked by BoNT/A if the detergent OG was present. 
level, subfractionation studies and the analysis of isolated 
chromaffin vesicles show that stable SNAP-25 heterodimers, 
resistant to SDS at room temperature, xist in the chromaffin 
vesicle membrane. 
4. Discussion 
In the present study, we have shown that SNAP-25 exists in 
adrenal chromaffin cells not only at the plasmalemma but also 
at the membranes of catecholamine storing chromaffin vesi- 
cles. In chromaffin vesicles SNAP-25 and syntaxin form a 
binary complex, stable at room temperature even in the pres- 
ence of SDS. SNAP-25 and syntaxin are regarded as essential 
components of the exocytosis apparatus, because botulinum 
neurotoxins exert their inhibitory action on exocytosis by se- 
lective cleavage of these proteins. We propose that preexisting 
vesicular SNAP-25/syntaxin heterodimers, which have pre- 
viously been shown to associate with soluble SNAPs [4,7], 
participate in exocytotic vesicle docking and fusion as vesicu- 
lar SNAP receptors. 
In previous investigations resistance to SDS as a signature 
of high stability has only been observed in complexes of high- 
er order, that is in SNAP-25/syntaxin/synaptobrevin hetero- 
trimers [9,40]. Heterotrimeric complexes have been found in 
solubilized adrenal chromaffin and pheochromocytoma cells 
[13,36,41], in detergent extracts of brain and upon incubation 
of the recombinant proteins in media containing nonionic 
detergents [3,5,9,39,40]. These complexes, formed in the pres- 
ence of detergents in the aforementioned studies, are assumed 
to represent intermediates generated uring docking of synap- 
tic vesicles and chromaffin vesicles to the plasmalemmal target 
membrane, a process predicted by the SNARE hypothesis 
[2,3,22]. In adrenal chromaffin cells most secretory vesicles 
are undocked. Thus the stable heterodimers of SNAP-25 
and syntaxin found in the membranes of intact vesicles are 
likely precursors of heterotrimers which may be formed upon 
vesicle docking. 
Synaptobrevin, although present in the chromaffin vesicle 
membrane [12,37], does not associate with stable vesicular 
ll5 
SNAP-25/syntaxin heterodimers to form stable heterotrimers. 
Several reasons may account for this inability. First, synapto- 
brevin and SNAP-25/syntaxin heterodimers present in the 
same vesicle may have an inappropriate orientation for the 
formation of a heterotrimer as opposed to synaptobrevin 
a docked vesicle facing plasmalemmal syntaxin and SNAP-25. 
Second, protein-protein (or protein-lipid) interactions, for ex- 
ample binding of synaptotagmin [42,43], complexins [44] or 
secl homologues [4547] to syntaxin, may prevent he forma- 
tion of the heterotrimers in the vesicular membrane. Specifi- 
cally, n-secl inhibits the interaction of other proteins with 
syntaxin, including synaptobrevin and SNAP-25 [5]. A secl 
homologue associated with chromaffin vesicles [37] may pos- 
sess this function. Third, synaptobrevin binding to the hetero- 
dimer may require conformational changes in the components 
of the exocytosis apparatus which can be elicited in vitro by 
addition of detergent (see above) but may occur in vivo dur- 
ing vesicle docking or fusion. 
Syntaxin, SNAP-25/syntaxin heterodimers, SNAP-25/syn- 
taxin/synaptobrevin heterotrimers bind SNAPs but synapto- 
brevin alone does not [4,7,11]. Thus in adrenal chromaffin 
vesicles the observed stable SNAP-25/syntaxin heterodimers 
and syntaxin monomers are the only known SNAP receptors 
present. The complexes of SNAPs with recombinant syntaxin, 
heterodimers, and heterotrimers disassemble after binding of 
NSF in a ATP-dependent manner [3,4,6]. Thus it is possible 
that vesicular and/or cellular complexes between SNAPs, syn- 
taxin or the stable heterodimers can disassemble with ATP. 
Recently also synaptic vesicles have been shown to contain 
both SNAP-25 and syntaxin [48,49]. It is unknown whether 
SNAP-25 and syntaxin form heterodimers within the mem- 
branes of synaptic vesicles but it is interesting to note that 
syntaxin of synaptic vesicles was found to be susceptible to 
botulinum neurotoxin C1 [49]. This observation suggests that 
most syntaxin present in synaptic vesicle, similar to syntaxin 
in chromaffin vesicles (see above) is not bound to SNAP-25. 
However, vesicular complexes or monomers of SNAP-25 and 
syntaxin may serve as SNAP receptors operating during exo- 
cytosis. Interaction with soluble SNAPs and NSF may also 
occur in docked vesicles in which vesicular and plasmalemmal 
SNAP-25 and syntaxin are coupled via SNAPs and multi- 
meric NSF. In this scenario disassembly of this initial sym- 
metric complex could be followed by the formation of a het- 
erotrimer composed of vesicular synaptobrevin and 
plasmalemmal SNAP-25 and syntaxin. 
Recent functional studies revealed that SNAP-mediated 
pathways enhance exocytosis of synaptic vesicles and chro- 
marlin vesicles [50,51] implying that soluble SNAPs and 
NSF, detected first to be essential for constitutive fusion 
events (reviewed in [22]), also operate in regulated exocytosis. 
Clostridial neurotoxins made it possible to identify synapto- 
brevin, syntaxin and SNAP-25 as essential proteins of the 
exocytosis apparatus of neurons and endocrine cells. Accord- 
ing to the SNARE hypothesis pecificity of targeting during 
exocytosis is assured by complex formation between the v- 
SNARE synaptobrevin and syntaxin as well as SNAP-25, pre- 
viously located exclusively to the plasmalemma. However, re- 
cent observations (this study and [38,48,49]) have shown that 
SNAP-25 and syntaxin, as monomers or as heterodimers, are 
present in addition in the vesicular membrane. Thus these 
proteins may serve during exocytosis both as v- and t- 
SNAREs. For example during docking, vesicular and plasma- 
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lemmal SNAP-25 and syntaxin first coupled via SNAPs/NSF 
but then disassembled by ATP could be replaced by a com- 
plex between synaptobrevin and SNAP-25/syntaxin in the t- 
SNARE position. The resulting heterodimeric complexes bind 
again the soluble components NSF and SNAPs, in competi- 
tion with the vesicular calcium sensor synaptotagmin [52,53]. 
Subsequent steps may be followed by membrane fusion and 
neurotransmitter o hormone release. 
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